These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26875131)

  • 21. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term persistence with statin therapy: a nationwide register study in Finland.
    Helin-Salmivaara A; Lavikainen P; Korhonen MJ; Halava H; Junnila SY; Kettunen R; Neuvonen PJ; Martikainen JE; Ruokoniemi P; Saastamoinen LK; Virta L; Huupponen R
    Clin Ther; 2008; 30 Pt 2():2228-40. PubMed ID: 19281917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.
    Morrone D; Weintraub WS; Toth PP; Hanson ME; Lowe RS; Lin J; Shah AK; Tershakovec AM
    Atherosclerosis; 2012 Aug; 223(2):251-61. PubMed ID: 22410123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of adherence to statins for primary prevention.
    Mann DM; Allegrante JP; Natarajan S; Halm EA; Charlson M
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):311-6. PubMed ID: 17665294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.
    Ellis JJ; Erickson SR; Stevenson JG; Bernstein SJ; Stiles RA; Fendrick AM
    J Gen Intern Med; 2004 Jun; 19(6):638-45. PubMed ID: 15209602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin use in Brazil: findings and implications.
    do Nascimento RCRM; Guerra AA; Alvares J; Gomes IC; Godman B; Bennie M; Kurdi AB; de Acurcio FA
    Curr Med Res Opin; 2018 Oct; 34(10):1809-1817. PubMed ID: 29528246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standards of statin usage in Poland in high-risk patients: 3ST-POL study results.
    Sliż D; Filipiak KJ; Naruszewicz M; Siebert J; Mamcarz A
    Kardiol Pol; 2013; 71(3):253-9. PubMed ID: 23575780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet hyperactivity after statin treatment discontinuation.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Leo A; Cercignani M; Palazzuoli A; Auteri A; Bruni F
    Thromb Haemost; 2003 Sep; 90(3):476-82. PubMed ID: 12958617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study.
    Nielsen SF; Nordestgaard BG
    Eur Heart J; 2016 Mar; 37(11):908-916. PubMed ID: 26643266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.
    Karalis DG; Wild RA; Maki KC; Gaskins R; Jacobson TA; Sponseller CA; Cohen JD
    J Clin Lipidol; 2016; 10(4):833-841. PubMed ID: 27578114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness.
    Pirro M; Vaudo G; Lupattelli G; Pasqualini L; Mannarino MR; Schillaci G; Alaeddin A; Paciullo F; Fallarino F; Bagaglia F; Mannarino E
    Life Sci; 2013 Sep; 93(8):338-43. PubMed ID: 23871987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonadherence to statin therapy: discontinuation after a single fill.
    Lemstra M; Blackburn D
    Can J Cardiol; 2012; 28(5):567-73. PubMed ID: 22658124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.
    Ho LT; Yin WH; Chuang SY; Tseng WK; Wu YW; Hsieh IC; Lin TH; Li YH; Huang LC; Wang KY; Ueng KC; Fang CC; Pan WH; Yeh HI; Wu CC; Chen JW;
    PLoS One; 2015; 10(3):e0116513. PubMed ID: 25756522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary nonadherence to statin medications in a managed care organization.
    Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
    J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term treatment with statins in patients with ischemic heart disease after coronary angioplasty].
    Skulec R; Linhart A; Hnátek T; Spundová H; Mrázek V; Bĕlohlávek J; Holm F; Aschermann M
    Vnitr Lek; 2003 Apr; 49(4):285-90. PubMed ID: 12793051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.